Synthesis, activation and deactivation of glucocorticoids. The biological role of cortisol in metabolic disorders
In the light of the emerging new data, the view of the hypothalamic-pituitary-adrenal-target organs system undergoes significant changes, and along with the negative feedback mechanism, there are suggestions of the existence of other regulatory mechanisms for synthesis, activation, and deactivation...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Endocrinology Research Centre
2017-09-01
|
Series: | Ожирение и метаболизм |
Subjects: | |
Online Access: | https://endojournals.ru/index.php/omet/article/view/8791 |
id |
doaj-8a5c6280c7b24fb587ff43ef7e37331d |
---|---|
record_format |
Article |
spelling |
doaj-8a5c6280c7b24fb587ff43ef7e37331d2021-10-02T16:10:12ZengEndocrinology Research CentreОжирение и метаболизм2071-87132306-55242017-09-01142485210.14341/omet2017248-527865Synthesis, activation and deactivation of glucocorticoids. The biological role of cortisol in metabolic disordersEkaterina V. Artemova0<p>ФГБУ Эндокринологический научный центр Минздрава России</p>In the light of the emerging new data, the view of the hypothalamic-pituitary-adrenal-target organs system undergoes significant changes, and along with the negative feedback mechanism, there are suggestions of the existence of other regulatory mechanisms for synthesis, activation, and deactivation of glucocorticosteroids (GCS). However, there is currently a relatively small amount of data on the relationship between systemic and local cortisol production in tissues. The inconsistent increase in the number of patients with diabetes mellitus (predominantly type 2) and obesity poses new challenges in developing effective medicines and their delivery forms, Methods of timely detection and prevention of the development of the disease. Understanding these processes will create the necessary scientific basis for the search and development of new targets for the pharmacotherapy of diseases associated with a violation of synthesis, activation and action of GCS.https://endojournals.ru/index.php/omet/article/view/8791Кортизолвненадпочечниковая продукциянеоваскулогенезкардиоваскулярные рискирепарация тканей |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ekaterina V. Artemova |
spellingShingle |
Ekaterina V. Artemova Synthesis, activation and deactivation of glucocorticoids. The biological role of cortisol in metabolic disorders Ожирение и метаболизм Кортизол вненадпочечниковая продукция неоваскулогенез кардиоваскулярные риски репарация тканей |
author_facet |
Ekaterina V. Artemova |
author_sort |
Ekaterina V. Artemova |
title |
Synthesis, activation and deactivation of glucocorticoids. The biological role of cortisol in metabolic disorders |
title_short |
Synthesis, activation and deactivation of glucocorticoids. The biological role of cortisol in metabolic disorders |
title_full |
Synthesis, activation and deactivation of glucocorticoids. The biological role of cortisol in metabolic disorders |
title_fullStr |
Synthesis, activation and deactivation of glucocorticoids. The biological role of cortisol in metabolic disorders |
title_full_unstemmed |
Synthesis, activation and deactivation of glucocorticoids. The biological role of cortisol in metabolic disorders |
title_sort |
synthesis, activation and deactivation of glucocorticoids. the biological role of cortisol in metabolic disorders |
publisher |
Endocrinology Research Centre |
series |
Ожирение и метаболизм |
issn |
2071-8713 2306-5524 |
publishDate |
2017-09-01 |
description |
In the light of the emerging new data, the view of the hypothalamic-pituitary-adrenal-target organs system undergoes significant changes, and along with the negative feedback mechanism, there are suggestions of the existence of other regulatory mechanisms for synthesis, activation, and deactivation of glucocorticosteroids (GCS). However, there is currently a relatively small amount of data on the relationship between systemic and local cortisol production in tissues. The inconsistent increase in the number of patients with diabetes mellitus (predominantly type 2) and obesity poses new challenges in developing effective medicines and their delivery forms, Methods of timely detection and prevention of the development of the disease. Understanding these processes will create the necessary scientific basis for the search and development of new targets for the pharmacotherapy of diseases associated with a violation of synthesis, activation and action of GCS. |
topic |
Кортизол вненадпочечниковая продукция неоваскулогенез кардиоваскулярные риски репарация тканей |
url |
https://endojournals.ru/index.php/omet/article/view/8791 |
work_keys_str_mv |
AT ekaterinavartemova synthesisactivationanddeactivationofglucocorticoidsthebiologicalroleofcortisolinmetabolicdisorders |
_version_ |
1716852740522508288 |